Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients.

Por Elza C de Bruin, Jessica L Whiteley, Claire Corcoran, Pauline M Kirk, Jayne C Fox, Javier Armisen, Justin P O Lindemann, Gaia Schiavon, Helen J Ambrose, Alexander Kohlmann
Publicado em 2017-01-01